FEDERATED HERMES, INC. - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,197,273
-55.8%
2,451,544
-0.7%
0.01%
-51.7%
Q2 2023$11,753,863
+24.0%
2,469,299
+48.5%
0.03%
+20.8%
Q1 2023$9,475,230
+63.2%
1,662,321
+188.8%
0.02%
+50.0%
Q4 2022$5,806,956
+107.2%
575,516
+360.4%
0.02%
+100.0%
Q3 2022$2,802,000
-17.7%
125,003
-9.0%
0.01%
-11.1%
Q2 2022$3,406,000
-29.7%
137,419
+9.9%
0.01%
-18.2%
Q1 2022$4,846,000
-33.7%
125,0000.0%0.01%
-21.4%
Q4 2021$7,314,000
-1.3%
125,0000.0%0.01%0.0%
Q3 2021$7,409,000
-31.7%
125,0000.0%0.01%
-30.0%
Q2 2021$10,849,000
-34.1%
125,000
-37.4%
0.02%
-37.5%
Q1 2021$16,472,000
-28.3%
199,785
-20.9%
0.03%
-31.9%
Q4 2020$22,969,000
+111.9%
252,601
-6.9%
0.05%
+88.0%
Q3 2020$10,842,000
-13.7%
271,258
-25.9%
0.02%
-19.4%
Q2 2020$12,559,000
+21.7%
366,052
-21.2%
0.03%
+3.3%
Q1 2020$10,317,000
+114.1%
464,514
+95.7%
0.03%
+150.0%
Q2 2019$4,818,000
-40.2%
237,317
-48.3%
0.01%
-40.0%
Q1 2019$8,062,000
+79.7%
458,869
+31.2%
0.02%
+66.7%
Q4 2018$4,487,000
+9.9%
349,751
+39.6%
0.01%
+20.0%
Q3 2018$4,081,000
+408000.0%
250,464
+247884.2%
0.01%
Q1 2018$1,000
-66.7%
101
-77.7%
0.00%
Q4 2017$3,000
-40.0%
452
-61.4%
0.00%
Q1 2017$5,0001,1700.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders